Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Guilford, CT, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Hyperfine Research has closed an oversubscribed $90 Million Series D financing round, with support from investors including GV (formerly Google...
-
SAN JOSE, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United...
-
Philadelphia, PA, Feb. 04, 2021 (GLOBE NEWSWIRE) -- VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt 5VS) (OTC: VSBGF) (“VSBLTY”), a leading provider of security and retail marketing...
-
SAN JOSE, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
-
ATLANTA, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Apogee Interactive Inc., a leading provider of customer engagement software to hundreds of North American energy utilities, has named Nils Frenkel as Vice...
-
Guilford, CT, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Internationally-respected neuroradiologist Edmond “Eddie” Knopp, M.D. has joined Hyperfine Research, Inc. as the company’s Senior Medical Director....
-
Guilford, CT, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Hyperfine Research, Inc. has received 510(k) clearance from the US FDA for its deep-learning image analysis software. These Advanced AI Applications...
-
- 與 Richard Childs 博士的合作獲得全球首個靶向腎細胞癌相關的人類內源性逆轉錄病毒潛在抗體 加州三藩市和中國蘇州, Jan. 14, 2021 (GLOBE NEWSWIRE) -- 具備精準抗體發現和開發能力的平台驅動型生物製藥企業天演藥業（蘇州）有限公司今日宣佈，圓滿完成與 Richard Childs 博士的合作中由天演藥業負責的抗體發現工作。Richard...
-
SAN JOSE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Zoom Video Communications, Inc. (NASDAQ: ZM) today announced that it has sold one million Zoom Phone seats shortly before it reached the two-year...
-
加州旧金山和中国苏州, Jan. 12, 2021 (GLOBE NEWSWIRE) -- 具备精准抗体发现和开发能力的平台驱动型生物制药企业天演药业（苏州）有限公司今天宣布，圆满完成与Richard Childs博士的合作中由天演药业负责的抗体发现工作。Richard...